Nephrol Dial Transplant (2000) 15: 778-785
© 2000 European Renal Association-European Dialysis and Transplant Association
Characterization of a DNA binding site that mediates the stimulatory effect of cyclosporin-A on type III collagen expression in renal cells
1 Nephrology Section, G. Gaslini Childrens Hospital, 2 Laboratory of Molecular Genetics, G. Gaslini Childrens Hospital and Department of Oncology Biology and Genetics, University of Genova, Italy
Background. Previous work from our laboratory demonstrated upregulation of type III collagen by cyclosporin A (CsA) in a cellular model of renal fibroblasts ‘in vitro’, suggesting that a mechanism of gene transcriptional activation might be responsible for collagen accumulation in renal fibrosis resulting from chronic CsA treatment.
Methods. We analysed in the same cellular model: (i) COL3A1 mRNA expression by RT–PCR; (ii) COL3A1 promoter activity by transfection of renal fibroblasts with constructs containing promoter fragments of different length fused to a reporter gene; (iii) expression of transcription factors by western blot analysis; (iv) DNA–protein binding by gel retardation assays with nuclear extracts from CsA-treated and untreated cells; and (v) site-directed mutagenesis of COL3A1 promoter to verify the role of a short DNA segment as CsA responsive element.
Results. CsA induced a 3–5-fold increase in COL3A1 mRNA that was paralleled by a stimulation of the COL3A1 promoter. Degradation of COL3A1 mRNA was comparable in CsA-treated and -untreated cells. The target region was first limited to a 178 bp fragment from -117 to +61 (pFV1). By gel retardation, utilizing several oligonucleotides that covered the whole length of pFV1, we detected a factor able to bind the promoter DNA (oligo 31) in nuclear extracts after 3 h treatment with CsA. The binding was absent in untreated cells and it was not detected when a 10-base mutation was introduced in oligonucleotide 31. Finally, the same substitution mutation at the site of binding of this factor abolished the stimulatory effect of CsA on COL3A1 promoter. Some transcription factors, whose potential binding sites are included in the above promoter fragment, were induced by CsA treatment either soon (3 h) or late (24–72 h) after treatment and were detected by western blot analysis.
Conclusions. CsA induces the synthesis of type III collagen by stimulating a pathway leading to activation of COL3A1 promoter and upregulation of COL3A1 mRNA. A short promoter fragment, proximal to the transcription start site, is the target of CsA stimulation.
Keywords: COL3A1; cyclosporin; renal fibrosis; type III collagen
Correspondence and offprint requests to: Dr Gian Marco Ghiggeri, Nephrology Section, G. Gaslini Childrens Hospital, Largo G. Gaslini 5, 16148 Genova, Italy.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. C. Roos-van Groningen, E. M. Scholten, P. M. Lelieveld, A. T. Rowshani, H. J. Baelde, I. M. Bajema, S. Florquin, F. J. Bemelman, E. de Heer, J. W. de Fijter, et al. Molecular Comparison of Calcineurin Inhibitor-Induced Fibrogenic Responses in Protocol Renal Transplant Biopsies J. Am. Soc. Nephrol., March 1, 2006; 17(3): 881 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C. Bakker, K. Koop, Y. W. Sijpkens, M. Eikmans, I. M. Bajema, E. de Heer, J. A. Bruijn, and L. C. Paul Early Interstitial Accumulation of Collagen Type I Discriminates Chronic Rejection from Chronic Cyclosporine Nephrotoxicity J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2142 - 2149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Giampuzzi, G. Botti, M. Di Duca, L. Arata, G. Ghiggeri, R. Gusmano, R. Ravazzolo, and A. Di Donato Lysyl Oxidase Activates the Transcription Activity of Human Collagene III Promoter. POSSIBLE INVOLVEMENT OF Ku ANTIGEN J. Biol. Chem., November 10, 2000; 275(46): 36341 - 36349. [Abstract] [Full Text] [PDF]
|
|